Dapavo, Paolo, Matteo Megna, and Marina Talamonti. 2024. “Efficacy of Tildrakizumab 200 Mg for Treating Difficult-to-Treat Patient Populations With Moderate to Severe Plaque Psoriasis”. Dermatology Reports, August. https://doi.org/10.4081/dr.2024.9999.